When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Should You Get Your COVID-19 Vaccine and Flu Shot on ... - AOL

   www.aol.com/covid-19-vaccine-flu-shot-175444974.html

   Pneumonia vaccine (PCV13) and meningococcal conjugate vaccine. You can’t give the PCV13 pneumonia shot with a meningococcal conjugate vaccine, as they may interfere with your body’s ...

3. The most common side effects to expect after your Pfizer ...

   www.aol.com/news/most-common-side-effects-expect...

   After a third shot of Pfizer's vaccine, injection-site pain is most common side effect, followed by fatigue and headache. The most common side effects to expect after your Pfizer booster: headache ...

4. These Are the 6 Vaccines Doctors Are Begging Everyone Over 50 ...

   www.aol.com/6-vaccines-doctors-begging-everyone...

   It may cause some mild side effects, such as pain in your arm, and he suggests planning to rest for a day or two after the shot. Research shows that the vaccine is most effective in the first year ...

5. Meningococcal vaccine - Wikipedia

   en.wikipedia.org/wiki/Meningococcal_vaccine

   Meningococcal vaccine refers to any vaccine used to prevent infection by Neisseria meningitidis. [9] Different versions are effective against some or all of the following types of meningococcus: A, B, C, W-135, and Y. [ 9 ] [ 10 ] The vaccines are between 85 and 100% effective for at least two years. [ 9 ]

6. Advisory Committee on Immunization Practices - Wikipedia

   en.wikipedia.org/wiki/Advisory_Committee_on...

   On February 26, 2015, ACIP voted to deliver a Category A recommendation for administering MenB vaccines to persons older than 10 years who were at higher risk of meningococcal disease. On June 24, 2015, ACIP heard the arguments for recommending Pfizer and Novartis's serogroup B meningococcal vaccines for everyone in the 16-22 age group.

7. Pneumococcal polysaccharide vaccine - Wikipedia

   en.wikipedia.org/wiki/Pneumococcal...

   The most common adverse reactions (reported in more than 10% of subjects vaccinated with pneumococcal polysaccharide vaccine in clinical trials) were: pain, soreness or tenderness at the site of injection (60.0%), injection-site swelling or temporary thickening or hardening of the skin (20.3%), headache (17.6%), injection-site redness (16.4%), weakness and fatigue (13.2%), and muscle pain (11.9%).

8. A ‘new turning point’: Patients could soon have a new shot to ...

   www.aol.com/turning-point-patients-could-soon...

   Pfizer’s new meningococcal vaccine, Penbraya, protects against five kinds of bacteria and could soon be an option that offers people broad protection from meningococcal disease with fewer shots ...

9. Pneumococcal conjugate vaccine - Wikipedia

   en.wikipedia.org/wiki/Pneumococcal_conjugate_vaccine

   Prevnar vaccine. Prevnar 20 (PCV20) is the third version of a vaccine produced by the Wyeth subsidiary of Pfizer.In April 2023, the FDA approved Prevnar 20 for the prevention of invasive disease caused by the 20 different serotypes of S. pneumoniae contained in the vaccine (serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, and 33F) for individuals 6 ...